134 related articles for article (PubMed ID: 10430044)
1. Monoclonal antibodies raised against human acetylcholine receptor bind to all five subunits of the fetal isoform.
Jacobson L; Beeson D; Tzartos S; Vincent A
J Neuroimmunol; 1999 Aug; 98(2):112-20. PubMed ID: 10430044
[TBL] [Abstract][Full Text] [Related]
2. Expression of human-Torpedo hybrid acetylcholine receptor (AChR) for analysing the subunit specificity of antibodies in sera from patients with myasthenia gravis (MG).
Loutrari H; Kokla A; Trakas N; Tzartos SJ
Clin Exp Immunol; 1997 Sep; 109(3):538-46. PubMed ID: 9328134
[TBL] [Abstract][Full Text] [Related]
3. Use of Torpedo-mouse hybrid acetylcholine receptors reveals immunodominance of the alpha subunit in myasthenia gravis antisera.
Loutrari H; Tzartos SJ; Claudio T
Eur J Immunol; 1992 Nov; 22(11):2949-56. PubMed ID: 1385157
[TBL] [Abstract][Full Text] [Related]
4. Epitope mapping of monoclonal antibodies to Torpedo acetylcholine receptor gamma subunits, which specifically recognize the epsilon subunit of mammalian muscle acetylcholine receptor.
Nelson S; Shelton GD; Lei S; Lindstrom JM; Conti-Tronconi BM
J Neuroimmunol; 1992 Jan; 36(1):13-27. PubMed ID: 1370956
[TBL] [Abstract][Full Text] [Related]
5. The conformation of the main immunogenic region on the alpha-subunit of muscle acetylcholine receptor is affected by neighboring receptor subunits.
Fostieri E; Beeson D; Tzartos SJ
FEBS Lett; 2000 Sep; 481(2):127-30. PubMed ID: 10996310
[TBL] [Abstract][Full Text] [Related]
6. Reconstitution of conformationally dependent epitopes on the N-terminal extracellular domain of the human muscle acetylcholine receptor alpha subunit expressed in Escherichia coli: implications for myasthenia gravis therapeutic approaches.
Tsouloufis T; Mamalaki A; Remoundos M; Tzartos SJ
Int Immunol; 2000 Sep; 12(9):1255-65. PubMed ID: 10967020
[TBL] [Abstract][Full Text] [Related]
7. Mapping of a cholinergic binding site by means of synthetic peptides, monoclonal antibodies, and alpha-bungarotoxin.
Conti-Tronconi BM; Tang F; Diethelm BM; Spencer SR; Reinhardt-Maelicke S; Maelicke A
Biochemistry; 1990 Jul; 29(26):6221-30. PubMed ID: 2207067
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of monoclonal antibodies to denatured Torpedo and to native calf acetylcholine receptors: species, subunit and region specificity.
Tzartos S; Langeberg L; Hochschwender S; Swanson LW; Lindstrom J
J Neuroimmunol; 1986 Jan; 10(3):235-53. PubMed ID: 3484485
[TBL] [Abstract][Full Text] [Related]
9. Temperature-sensitive expression of all-Torpedo and Torpedo-rat hybrid AChR in mammalian muscle cells.
Paulson HL; Claudio T
J Cell Biol; 1990 May; 110(5):1705-17. PubMed ID: 2335568
[TBL] [Abstract][Full Text] [Related]
10. Main immunogenic region of Torpedo electroplax and human muscle acetylcholine receptor: localization and microheterogeneity revealed by the use of synthetic peptides.
Tzartos SJ; Loutrari HV; Tang F; Kokla A; Walgrave SL; Milius RP; Conti-Tronconi BM
J Neurochem; 1990 Jan; 54(1):51-61. PubMed ID: 1688377
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibodies to cytoplasmic domains of the acetylcholine receptor.
Froehner SC; Douville K; Klink S; Culp WJ
J Biol Chem; 1983 Jun; 258(11):7112-20. PubMed ID: 6189834
[TBL] [Abstract][Full Text] [Related]
12. Future therapeutic strategies in autoimmune myasthenia gravis.
Psaridi-Linardaki L; Mamalaki A; Tzartos SJ
Ann N Y Acad Sci; 2003 Sep; 998():539-48. PubMed ID: 14592926
[TBL] [Abstract][Full Text] [Related]
13. Physicochemical and immunological studies of the N-terminal domain of the Torpedo acetylcholine receptor alpha-subunit expressed in Escherichia coli.
Alexeev T; Krivoshein A; Shevalier A; Kudelina I; Telyakova O; Vincent A; Utkin Y; Hucho F; Tsetlin V
Eur J Biochem; 1999 Jan; 259(1-2):310-9. PubMed ID: 9914508
[TBL] [Abstract][Full Text] [Related]
14. Assembly of Torpedo acetylcholine receptors in Xenopus oocytes.
Saedi MS; Conroy WG; Lindstrom J
J Cell Biol; 1991 Mar; 112(5):1007-15. PubMed ID: 1999453
[TBL] [Abstract][Full Text] [Related]
15. Functional and non-functional isoforms of the human muscle acetylcholine receptor.
Newland CF; Beeson D; Vincent A; Newsom-Davis J
J Physiol; 1995 Dec; 489 ( Pt 3)(Pt 3):767-78. PubMed ID: 8788941
[TBL] [Abstract][Full Text] [Related]
16. Evidence against acetylcholine receptor having a main immunogenic region as target for autoantibodies in myasthenia gravis.
Lennon VA; Griesmann GE
Neurology; 1989 Aug; 39(8):1069-76. PubMed ID: 2474772
[TBL] [Abstract][Full Text] [Related]
17. Human IgG monoclonal autoantibodies against muscle acetylcholine receptor: direct evidence for clonal heterogeneity of the antiself humoral response in myasthenia gravis.
Cardona A; Garchon HJ; Vernet-der-Garabedian B; Morel E; Gajdos P; Bach JF
J Neuroimmunol; 1994 Aug; 53(1):9-16. PubMed ID: 8051300
[TBL] [Abstract][Full Text] [Related]
18. Modulation of the anti-acetylcholine receptor response and experimental autoimmune myasthenia gravis by recombinant fragments of the acetylcholine receptor.
Barchan D; Asher O; Tzartos SJ; Fuchs S; Souroujon MC
Eur J Immunol; 1998 Feb; 28(2):616-24. PubMed ID: 9521072
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies against the acetylcholine receptor gamma-subunit as site specific probes for receptor tyrosine phosphorylation.
Tzartos SJ; Tzartos E; Tzartos JS
FEBS Lett; 1995 Apr; 363(1-2):195-8. PubMed ID: 7537227
[TBL] [Abstract][Full Text] [Related]
20. A conserved disulfide loop facilitates conformational maturation in the subunits of the acetylcholine receptor.
Walcott EC; Sumikawa K
Brain Res Mol Brain Res; 1996 Sep; 41(1-2):289-300. PubMed ID: 8883962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
